COCHLÉROB

Perceptual deafness affecting the neurosensory part (mainly the cochlea) is supported by amplification of sound signals or by placing a cochlear implant. Cochlear implantation is a technique of auditory rehabilitation for severe and profound deafness. His indications today extend to less severe cochlear pathologies with residual hearing. The medical and surgical challenge of these new indications is to insert these implants into the cochlea while preserving this fragile residual hearing. This goal is achieved in 70 to 90% of cases postoperatively. These success rates can be improved by several therapeutic agents. Difficulties of diffusion of the drugs in the inner ear are related to several barriers (the hemato-perilymphatic barrier and the round window). Nanoparticles represent a solution for the future as a carrier of drugs in the inner ear, because they move in the cochlea with a minimal hydrodynamic force, under the effect of an external magnetic field. The objective of the CochléRob project is to contribute to the development of innovative procedures for the administration of drugs (therapeutic agents) in the inner ear using super-paramagnetic nanoparticles (NPSPM) powered by magnetic fields.

Retombées du projet

Publication scientifique : 28

Emplois crées : 6

Thèse : 6

Produit / Prototype : 8

Nouveau projet : 4

Personnes engagées sur le projet
Informations sur le projet

Début du projet le 11 / 05 / 2021 | Fin du projet le 11 / 05 / 2021


Domaines d'activité stratégiques

Matériaux et composants pour l'électronique

Ces projets pourraient vous intéresser

Retour aux projets

Consulter les appels à projets

Vous avez une idée de projet à développer ?

Découvrez les appels à projets

Je souhaite être accompagné !

Besoin d'un accompagnement pour vos projets ?

Demande d'adhésion